Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels.
Rubin BS, Murray MK, Damassa DA, King JC, Soto AM. · 2001
Read Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. by Rubin BS, Murray MK, Damassa DA, King JC, Soto AM. (2001) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1240370.txt.
Introduction
Rubin and co-authors tested low-dose bisphenol A in rats in 2001. Bisphenol A, or BPA, is a building block of hard plastics. It can leak from can linings, dental sealants, and bottles. Though weakly estrogen-like, low doses were assumed safe.
Pregnant rats drank water with low or higher BPA doses. Exposure ran through pregnancy and nursing. Pups exposed early gained more weight from birth into adulthood. Females on the higher dose showed altered cycles. Their levels of a key reproductive hormone also dropped. Rubin shows early low-dose exposure can leave lasting marks.
Catalog record
| CREATOR | Rubin BS, Murray MK, Damassa DA, King JC, Soto AM. |
|---|---|
| YEAR | 2001 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. By B S Rubin, M K Murray, D A Damassa, J C King, A M Soto Published in: Environmental Health Perspectives DOI: 10.1289/ehp.01109675 ABSTRACT The nonsteroidal estrogenic compound bisphenol A (BPA) is a monomer used in the manufacture of polycarbonate plastics and resins. BPA may be ingested by humans as it reportedly leaches from the lining of tin cans into foods, from dental sealants into saliva, and from polycarbonate bottles into their contents. Because BPA is weakly estrogenic--approximately 10,000-fold less potent than 17beta-estradiol--current environmental exposure levels have been considered orders of magnitude below the dose required for adverse effects on health. Herein we demonstrate measurable effects on the offspring of Sprague-Dawley female rats that were exposed, via their drinking water, to approximately 0.1 mg BPA/kg body weight (bw)/day (low dose) or 1.2 mg BPA/kg bw/day (high dose) from day 6 of pregnancy through the period of lactation. Offspring exposed to BPA exhibited an increase in body weight that was apparent soon after birth and continued into adulthood. In addition, female offspring exposed perinatally to the high dose of BPA exhibited altered patterns of estrous cyclicity and decreased levels of plasma luteinizing hormone (LH) in adulthood. Administration of neither the doses of BPA that caused effects during perinatal exposure nor a 10-fold higher dose was able to evoke a uterotropic response in ovariectomized postpubertal females. These data indicate an increased sensitivity to BPA during the perinatal period and suggest the need for careful evaluation of the current levels of exposure to this compound. Environmental Health Perspectives * VOLUME 109 | NUMBER 7 | July 2001 675 Perinatal Exposure to Low Doses of Bisphenol A Affects Body Weight, Patterns of Estrous Cyclicity, and Plasma LH Levels Beverly S. Rubin, Mary K. Murray, David A. Damassa, Joan C. King, and Ana M. Soto Department of Anatomy and Cellular Biology, Tufts Medical School, Boston, Massachusetts, USA Estrogens exert a powerful influence during development that can permanently affect neuroendocrine function as well as the devel- opment and endocrine control of reproduc- tive tract tissues and the mammary glands. The revelation that some environmental chemicals can mimic the effects of estrogens raises concerns for human health, particu- larly when exposure occurs at stages of tissue organization and development such as dur- ing gestation or during the neonatal period of life (1). One such chemical is bisphenol A (BPA), a monomer used in the manufacture of polycarbonate plastics and resins. Low levels of BPA may be ingested routinely by humans as the compound leaches from the lining of tin cans into foods (2), from dental sealants into saliva (3), and from polycar- bonate bottles into their contents (4). BPA is approximately 10,000-fold less potent than 17-estradiol when tested for prolifera- tive activity and indigenous gene expression in estrogen-responsive cultured cell lines (3,5), in reporter gene assays (6,7), and in receptor binding assays (8). Because of its low potency relative to estradiol, current environmental exposure levels to BPA have been considered orders of magnitude below the dose required for adverse effects on health (9). Studies in rodent models have yielded conflicting results regarding the effects of exposure to BPA that are influenced by the species and by the specific strains examined as well as by the dose, the route of administra- tion, and the time of exposure (10-16). For example, Fischer 344 rats appear to be particu- larly sensitive to BPA. Ovariectomized animals exhibited approximately a 2-fold increase in uterine wet weight following 3 days of expo- sure to 0.3 mg BPA/kg body weight (bw) delivered by a subcutaneous implant (10). In contrast, identical treatment had no effect on uterine wet weight in Sprague-Dawley females (10). Prepubertal Long Evans rats showed a significant increase in uterine wet weight in response to 200 mg BPA/kg bw/day for 3 days; however, administration of 100 mg BPA/kg bw in the same regimen was ineffec- tive (16). Immature Alpk:AP rats exhibited a uterotropic response to 400 mg BPA/kg bw as evidenced by a 1.3-fold and a 1.5-fold increase in wet weight after oral gavage and subcuta- neous injection, respectively (17). Although some evidence suggests that mice may be less likely than rats to exhibit a uterotropic response to BPA (6), results of a recent study revealed that the continuous subcutaneous administration of 100 mg BPA/kg bw/day for 3 days did elicit a uterotropic response in CD1 mice (18). Other end points that have been studied after BPA administration to adult ani- mals--such as induction of cell proliferation in the uterus and the vagina, and prolactin secretion--also revealed differences in sensitiv- ity among rat strains (10,11). Again, Sprague- Dawley rats proved less sensitive to BPA than Fisher 344 rats in these studies. The route and time of exposure can also affect the potency of BPA. Results of a recent study indicated that the relative bioavailability of BPA is lower after oral administration than after subcutaneous or intraperitoneal delivery (15). Consistent with those data, Laws and colleagues (16) demonstrated a greater increase in uterine wet weight in response to subcutaneous delivery relative to oral adminis- tration of equivalent levels of BPA to imma- ture female rats. With regard to the time of exposure, oral administration of very low lev- els of BPA (0.002-0.020 mg/kg) to pregnant (CF-1) mice during days 11-17 of gestation produced measurable effects in their offspring (12,13). Significant alterations have also been reported in the behavior of the offspring of female Sprague-Dawley rats that were treated with 0.040-0.40 mg/kg BPA during preg- nancy and lactation (19). To date, there is no evidence that these same levels of BPA expo- sure would exert measurable effects in adults of the same species and strain. The particular consequences of estro- genic exposure and the mechanisms involved undoubtedly differ depending on the time of exposure. Limited exposure of adult animals to estrogenic compounds can produce effects that are mostly reversible when exposure ceases. In contrast, perinatal exposure to exogenous estrogenic compounds is likely to produce organizational effects that are irre- versible (20,21). To date, the limited num- ber of studies that have examined the effects of perinatal BPA exposure have used differ- ent species, strains, doses, and routes of administration, and they have measured dif- ferent end points (13,14,19,22). Hence, integrating the available data into a coherent picture has proven difficult. The aim of the present study was to assess the effects of BPA during development and to compare the sen- sitivity of the developing organism with that of the adult animal. An oral route of BPA Address correspondence to A. Soto, Department of Anatomy and Cellular Biology, Tufts Medical School, 136 Harison Avenue, Boston, MA 02111 USA. Telephone: (617) 636-6954. Fax: (617) 636- 6536. E-mail: [email protected] We acknowledge the technical assistance of C. Lee, C. Michaelson, R. O'Donnell, P. Ronsheim, and G. Shin. Support for these studies was provided by the Tufts Institute of the Environment and NIH-ES 08314. Received 23 August 2000; accepted 26 January 2001. Articles The nonsteroidal estrogenic compound bisphenol A (BPA) is a monomer used in the manufacture of polycarbonate plastics and resins. BPA may be ingested by humans as it